|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1401 Eye Street, NW |
Address2 | Suite 800 |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 314911-1004571
|
||||||||
|
6. House ID# 391710160
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Karen Blitz |
Date | 10/15/2020 3:25:00 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Nursing Workforce Development Programs (Title VIII, Public Health Service Act), NIH, NINR, HRSA, for FY2021
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021
Nurse Staffing
Workplace violence prevention
TriService Nursing Research Program
Support for public health infrastructure
H.R. 7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
H.R. 7617 - Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alan |
Wheat |
|
Former Member of Congress from Missouri |
|
Julie |
Shroyer |
|
|
|
James |
Fleischmann |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 6390/S.3568 - Medical Supply Chain Emergency Act of 2020
H.R. 3911/ S.2842 - Increasing Access to Quality Cardiac Rehabilitation Care Act of 2019
Reducing Regulatory Burdens, including those relating to home infusion therapy, Medicare Conditions of Participation, and hospice certification
H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act
H.R. 5800 - Ban Surprise Billing Act
Provider Non-Discrimination and Network Adequacy
S. 2074, HR 2482. Mainstreaming Addiction Treatment Act of 2019
H.R. 4974/S.4640 - Medication Access and Training Expansion (MATE) Act
Reducing Regulatory Burdens - Section 5 of Executive Order #13890 on Protecting and Improving Medicare for Our Nations Seniors
H.R.6800 - The Heroes Act
H.R.6809 - Nurse Workforce Protection Act of 2020
Support for public health infrastructure
Disproportionate impact of COVID-19 on communities of color
Emergency Relief Fund support
Nursing role in COVID-19 vaccine development, production, and distribution
H.R. 8061 - Community Immunity During COVID-19 Act
S.4315 - TRACE Act
Issues surrounding maternal vaccinations
S.4112 - Coronavirus Child Care and Education Relief Act
Support for school nurses
H.R. 925 - The Heroes Act
The Health, Economic Assistance, Liability Protections & Schools (HEALS) Act
S.178 - Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act
Personal Protective Equipment Standards and access to Personal Protective Equipment
Mental health resources for nurses
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alan |
Wheat |
|
Former Member of Congress from Missouri |
|
Julie |
Shroyer |
|
|
|
James |
Fleischmann |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 237/H.R. 808 - Promoting Access to Diabetic Shoes Act
CONNECT for Health Act of 2019 (S. 2741, H.R. 4932)
S.4541 - Nurse Overtime and Patient Safety Act of 2020
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alan |
Wheat |
|
Former Member of Congress from Missouri |
|
Julie |
Shroyer |
|
|
|
James |
Fleischmann |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 2056/S.997 - US Cadet Nurse Corps Service Recognition Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alan |
Wheat |
|
|
|
Julie |
Shroyer |
|
|
|
James |
Fleischmann |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Emergency Temporary Infectious Disease Standard
Personal Protective Equipment Standards and access to Personal Protective Equipment
Issues relating to leave and hazard pay
Workplace Safety Issues
Safe patient handling
S.851/H.R.1309 - Workplace Violence Prevention for Health Care and Social Service Workers Act
Mental health resources for nurses
Prioritizing COVID-19 testing and treatment of nurses
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Julie |
Shroyer |
|
|
|
Alan |
Wheat |
|
|
|
James |
Fleischmann |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
S.997/H.R. 2056 - US Cadet Nurse Corps Service Recognition Act
H.R. 6395/S.4049 - National Defense Authorization Act for Fiscal Year 2021
TriService Nursing Research Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alan |
Wheat |
|
|
|
Julie |
Shroyer |
|
|
|
James |
Fleischmann |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |